Open AccessMP62-18 ATENOLOL IS ASSOCIATED WITH REDUCED RISK OF PROSTATE CANCER UPGRADING: A MULTICENTER RETROSPECTIVE STUDY
Author(s) -
Ali H. Zahalka,
Ethan Fram,
Lauren Howard,
Evan Garden,
Larkin Mohn,
Jay Annam,
Allison L. Reagan,
Benjamin Eilender,
Amanda DeHoedt,
Emily Wiggins,
Ilir Agalliu,
Stephen Freedland,
Ash Tewari,
Kara Watts
Publication year - 2021
Publication title -
the journal of urology/the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1097/ju.0000000000002102.18
Subject(s) - atenolol , medicine , prostate cancer , β2 adrenergic receptor , cancer , library science , oncology , receptor , computer science , blood pressure , agonist